Inodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery

Author(s): Angela Ferrer-Barba, Iria Gonzalez-Rivera, Victor Bautista-Hernandez

Journal Name: Current Vascular Pharmacology

Volume 14 , Issue 1 , 2016

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Postoperative low cardiac output syndrome has been shown to have both a central and a peripheral vascular involvement. Therefore, inodilators which provide with a combination of positive inotropic and vasodilating therapy, conceptually should be an ideal form of treatment. However, contradictory data on these drugs exist. Phosphodiesterase inhibitors (e.g. milrinone) and more recently calcium sensitizers (e.g. levosimendan) have been most commonly used groups in the clinical setting. This review will summarize the pharmacology of inodilators with a special foccus on current clinical evidence. This article addresses the sixth of eight topics comprising the special issue entitled “Pharmacologic strategies with afterload reduction in low cardiac output syndrome after pediatric cardiac surgery”.

Keywords: Cardiac output syndrome, inodilators, levosimendan, milrinone, pediatric cardiac surgery, pharmacology.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 14 October, 2015
Page: [48 - 57]
Pages: 10
DOI: 10.2174/1570161113666151014125314

Article Metrics

PDF: 95
PRC: 4